Carregant...
Early onset of efficacy with erenumab in patients with episodic and chronic migraine
BACKGROUND: Subcutaneous erenumab reduced monthly migraine days and increased the likelihood of achieving a ≥ 50% reduction at all monthly assessment points tested in 2 pivotal trials in episodic migraine (EM) and chronic migraine (CM). Early efficacy of migraine preventive medications is an importa...
Guardat en:
| Publicat a: | J Headache Pain |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Milan
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755616/ https://ncbi.nlm.nih.gov/pubmed/30276500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0923-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|